Curium to Acquire Lantheus in Up to $8 Billion Radiopharma Deal

By EC Assets · Published 3 August 2026

Curium has announced a deal to acquire Lantheus for up to $8 billion. This acquisition aims to enhance Curium's position in radiopharmaceuticals. The transaction deepens Curium's radiopharma capabilities. This article is intended for informational purposes only. It does not constitute investment advice.